DFTX
Definium Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$38.09
+0.24%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−12.0x
Market Cap
$5.12B
MomentumView details →
1D Return
+0.24%
YTD Return
+183.72%
RSI (14)
36.7
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−12.0x
Market Cap
$5.12B
RSI (14)
36.7
MomentumView details →
1D Return
+0.24%
YTD Return
+183.72%
Similar companies
Latest newsMore news →
Definium Therapeutics issued inducement stock options to two newly hired non-executive employees to purchase an aggregate of 32,900 common shares, with effective grant dates of August 17, 2026.18d agoDefinium Therapeutics announced that its LSD therapy DT120 significantly eased anxiety in a late-stage Phase 3 trial for generalized anxiety disorder.23d ago